Cell proliferation effect of GnRH agonist on pathological lesions of women with endometriosis, adenomyosis and uterine myoma

By Khan Khaleque Newaz   Kitajima Michio   Hiraki Koichi   Fujishita Akira   Nakashima Masahiro   Ishimaru Tadayuki   Masuzaki Hideaki  

Human Reproduction, Vol. 25, Iss. 11, 2010-11 ,pp. : 2878-2890

Oxford University Press

Access to resources Recommend Favorite

Biochemical Markers as Predictors of Bone Mineral Density Changes After GnRH Agonist Treatment

By Borderie D.   Cherruau B.   Dougados M.   Ekindjian O. G.   Roux C.  

Calcified Tissue International, Vol. 62, Iss. 1, 1998-01 ,pp. : 21-25

Springer Publishing Company

Access to resources Recommend Favorite

Letter to the Editor. GnRH agonist versus antagonist therapy

By  

Human Reproduction, Vol. 17, Iss. 5, 2002-05 ,pp. : 1413-1413

Oxford University Press

Access to resources Recommend Favorite

Reproductive pathology. GnRH agonist-suppressed expression of nitric oxide synthases and generation of peroxynitrite in adenomyosis

By Kamada Yasuhiko   Nakatsuka Mikiya   Asagiri Kazuo   Noguchi Soichi   Habara Toshihiro   Takata Masayo  

Human Reproduction, Vol. 15, Iss. 12, 2000-12 ,pp. : 2512-2519

Oxford University Press

Access to resources Recommend Favorite

Long‐term effectiveness and safety of GnRH agonist plus raloxifene administration in women with uterine leiomyomas

By Palomba Stefano  

Human Reproduction, Vol. 19, Iss. 6, 2004-06 ,pp. : 1308-1314

Oxford University Press

Access to resources Recommend Favorite